Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery

This study has been completed.
Sponsor:
Information provided by:
Queen's University
ClinicalTrials.gov Identifier:
NCT00375167
First received: September 11, 2006
Last updated: April 14, 2008
Last verified: April 2008
  Purpose

The present study will determine if Spaniol and colleague's (1994) Recovery Workbook group intervention is an effective clinical tool to move a person with SMI along in their journey of recovery. The primary outcome measurements of this study will be the participants' perceived level of empowerment, hope and optimism, knowledge of recovery, and life satisfaction. This kind of information would add to the current body of knowledge about how principles of recovery can be used in psychoeducational programs used by outpatient community mental health services.


Condition Intervention Phase
Mental Disorders
Behavioral: Recovery Workbook Training (psychoeducational training)
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery in Persons With Severe and Persistent Mental Illness

Resource links provided by NLM:


Further study details as provided by Queen's University:

Primary Outcome Measures:
  • Hope
  • Empowerment
  • Knowledge of Recovery
  • Quality of life

Estimated Enrollment: 60
Study Start Date: September 2006
Estimated Study Completion Date: May 2008
Detailed Description:

ABSTRACT:

Objective: Adopting the principles of recovery into the mental health field has been a growing area for discussion at many different levels of care. The present study will determine if Spaniol and colleague's (1994) Recovery Workbook group intervention can be used as an effective clinical tool to move a person with a severe mental illness along in their journey of recovery. The primary outcome measurements of this study will be the participants' perceived level of empowerment, hope and optimism, knowledge of recovery, and life satisfaction. Method: The study will be a multicenter, prospective, single-blinded, randomized control trial. Sixty participants will be recruited from three Assertive Community Treatment Teams (ACTT) in Kingston, Ontario and individuals will be randomized to either the control or intervention arm of the study. The control arm of the study will receive their regular services from ACTT. The intervention arm will participate in a 10-week psychoeducational group program in addition to receiving their regular services from ACTT. Results: Analysis will be performed by intention to treat, based on total scores of four assessments which will be performed at the trial commencement and termination.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Receive support from an Assertive Community Treatment Team.
  2. Meet the DSM-IV diagnostic classification for schizophrenia, schizoaffective, schizophreniform, delusional disorder, or bipolar disorder.
  3. Aged 18-55 years-old.
  4. Individuals agree to participate in the study after they have been informed of all the expected benefits and risks.
  5. Neither substance misuse nor organic disorder judged to be the major cause of psychotic symptoms.

Exclusion Criteria:

  1. Inability to give informed consent
  2. Diagnosis of dementia
  3. Significant head injury or other brain injury leading to cognitive impairment
  4. Mental retardation (premorbid IQ < 65)
  5. Require an interpreter
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00375167

Locations
Canada, Ontario
Queen's University
Kingston, Ontario, Canada, K7L 3N6
Sponsors and Collaborators
Queen's University
Investigators
Principal Investigator: Skye Barbic, BScOT Queen's University
Principal Investigator: Terry Krupa, PhD Queen's University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00375167     History of Changes
Other Study ID Numbers: 1
Study First Received: September 11, 2006
Last Updated: April 14, 2008
Health Authority: Canada: Health Canada

Keywords provided by Queen's University:
Recovery, Hope, Empowerment, Randomized Control Trial

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on September 18, 2014